TrialESMO open2021

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.

M Reck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.